The WHO presentation reviewed the global status of HPV vaccine introduction, noting that 74% of countries have adopted HPV vaccination programs with increasing coverage driven by major introductions in Asia and Africa. It highlighted the 2022 recommendation for a single-dose schedule, now adopted by 58 countries, including high-income nations. Recent evidence supports the inclusion of […]
Topic: 3. The vaccine
HPV vaccination programme update
Bangladesh’s HPV vaccination campaign, launched in October 2023, began in Dhaka and expanded nationwide by October 2024, targeting girls aged 10–14. Registration through the VaxEPI system reached 5.6 million, with 4.8 million vaccinated—around 90% coverage. Key challenges included data gaps, birth registration barriers, underserved out‑of‑school populations, and vaccine hesitancy driven by misinformation. Field experience highlighted […]
Decision-making to switch to single dose
The presentation outlines Myanmar’s policy shift from a two-dose to a single-dose HPV vaccination schedule, driven by operational challenges during COVID-19, missed cohorts, and WHO’s updated recommendations. NITAG adopted a systematic, evidence-based approach using PICO criteria to guide decision-making, ensuring transparency and technical rigor. The revised strategy targets 9–11-year-old girls through school and community campaigns, […]
Single-dose scientific evidence data and implementation progress
The session reviewed global evidence underpinning the WHO’s 2022 recommendation for single-dose HPV vaccination. Data from pivotal trials in Costa Rica, India, and Kenya demonstrated sustained efficacy exceeding 80–90% against HPV 16/18 infection for over a decade. Immunogenicity studies confirmed durable antibody responses comparable to multi-dose schedules, with similar outcomes in boys and girls. Population-level […]
Evaluation of the Vaccine Effectiveness 11 years after 4vHPV Vaccination Among Young Women in Mongolia
This study evaluated the long-term effectiveness of the three-dose 4vHPV vaccine eleven years after a 2012 pilot program in Mongolia. It assessed women aged 24–28 for protection against HPV16/18 using self-collected vaginal samples and GenExpert testing. Results showed 88% effectiveness against vaccine-type HPV but no cross-protection against other high-risk types. Knowledge of HPV and cervical […]
The effectiveness of the HPV vaccine as part of the National Immunization Program for preventing HPV infection in Thai schoolgirls after seven years following immunization.
The study evaluated the long-term effectiveness of Thailand’s bivalent HPV vaccination program for schoolgirls, seven years post-administration. Conducted in Ayutthaya (vaccinated) and Nakhon Pathom (unvaccinated), urine samples were analyzed for 28 HPV types using Cobas®4800 and AnyplexTM HPV28 assays. Results showed 100% protection against HPV types 16 and 18 and partial cross-protection (32.8%) against other […]
Integrated service delivery to improve adolescent health and human pappilomavirus vaccination in Laos: a quasi-experimental mixed-methods study
The poster presents an integrated approach to enhance adolescent health and HPV vaccination uptake in Laos. It outlines a multi-stakeholder intervention led by Health Poverty Action and the University of Health Sciences, addressing gaps in sexual and reproductive health knowledge and service access. The initiative combines adolescent health services with HPV vaccination delivery to optimize […]
Assessment of HPV Vaccination Strategies to Reach Out-of-School Girls Across Indonesia
The study assessed Indonesia’s HPV vaccination strategies for reaching out‑of‑school girls following the 2023 nationwide scale‑up. Despite coverage of in‑school populations, findings revealed no formal strategies, decrees, or coordination mechanisms to reach marginalized groups such as girls in faith‑based schools, urban slums, orphanages, juvenile institutions, or those engaged in child labor. The assessment identified data […]
Considerations for school-based HPV immunization: А Nationwide survey in Mongolia
This qualitative study explored school-based HPV immunization in Mongolia following the 2023 amendment making HPV vaccination mandatory. Focus groups with 13 teachers from four regions revealed declining parental confidence in vaccines, misinformation, and logistical barriers, particularly in rural areas. Teachers highlighted challenges such as vaccine storage, transportation, and the need for clearer roles of school […]
Summary Report of Experiences of Human Papillomavirus (HPV) Introduction: Focus on the Introduction in Timor-Leste
The poster highlights Timor-Leste’s preparatory efforts for HPV vaccine introduction, focusing on coordination among the Ministries of Health, Education, and State Administration. It outlines strategies to register girls aged 11–14 both in and out of school and emphasizes advocacy through key influencers, including national leaders and community figures. The initiative targets 95% coverage, leveraging single-dose […]